Online (open access) and print journal

 Search | Legal Notice | Privacy | Disclaimer

You are here: Back issues » acp-2009 » acp-4-2009 » 03_spitzer

Catheter ablation of atrial fibrillation – Current status and future directions

S. G. Spitzer, L. Karolyi
Praxisklinik Herz und Gefäße Dresden, Akademische Lehrpraxisklinik der TU Dresden, Germany
[Applied Cardiopulmonary Pathophysiology 13: 291-299]


Atrial fibrillation (AF) is the most common arrhythmia experienced in clinical practice (approx. 1% predominance in adult population). To obtain sinus rhythm antiarrhythmic medications such as amiodarone have evolved as the most effective available and hence frequently used therapy. In contrast, its long-term efficacy turned out to be rather moderate and could cause serious side effects. Thus, catheter ablation seems to be a reasonable alternative in particular for patients with drug-refractory AF. However, the development in ablation strategies remains to be complex with often lengthy procedures. This study investigates whether a novel multielectrode catheter, delivering duty-cycled bipolar/unipolar RF energy, is feasible and safe. Therefore, 67 consecutive patients with paroxysmal/persistent AF have been analysed. PV isolation with the PVAC catheter was feasible and safe with shorter fluoroscopy/procedural results and good clinical efficacy at 6 months (stable sinus rhythm in 87%).

Key words: atrial fibrillation, antiarrhythmic medication, catheter ablation, pulmonary vein ablation catheter (PVAC)

Address for corresponding:
Stefan G. Spitzer, M.D., Praxisklinik Herz und Gefäße, Akademische Lehrpraxisklinik der TU Dresden, Forststr. 3, 01099 Dresden, Germany
Öffnet ein Fenster zum Versenden einer

alttext  printable view